Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Factors Are Driving the Anticipated Growth Rate of the Common Warts Market Through 2034?

Over the past few years, there has been substantial growth in the market size for common warts. Predictions indicate an increase from $2.13 billion in 2024 to $2.26 billion in 2025, presenting a compound annual growth rate (CAGR) of 6.2%. The historical growth has been motivated by a heightened consciousness of skin health, a higher occurrence of warts, surging needs for non-surgical methods, alongside an amplified use of cryotherapy. Additionally, the proliferation of dermatology clinics added to this expansion.

The market size for common warts is projected to witness significant growth in the coming years. It is expected to reach a value of $2.83 billion in 2029, with an annual compound growth rate (CAGR) of 5.8%. The predicted growth during this period can be linked to factors such as the increasing elderly population, the rising prevalence of viral infections, and the growing uptake of advanced dermatological therapies. Moreover, there is an increasing need for personalized treatments and a preference for homecare solutions amongst consumers. Key trends for the forecast period include advancements in dermatological treatments, the expansion of healthcare infrastructure, technological innovation in wart removal therapies, increased knowledge about different treatment options, and a transition towards less invasive treatments.

Which Factors Are Enhancing the Growth of the Common Warts Market?

The continuous surge in viral infections is anticipated to stimulate the expansion of the common warts market in the future. Viral infections characterize sicknesses that result from viruses infiltrating, proliferating, and disseminating within the body, affecting cells and the immune system. This surge in viral infections can be attributed to globalization, climate fluctuations, urbanization, deforestation, and compromised immune responses. The overarching aim of common warts treatment is to target the human papillomavirus (HPV), which is the culprit behind wart development. The treatment offers vital support to patients suffering from viral infections by decreasing the virus’s transmission, easing discomfort, and encouraging healing, thereby averting potential complications like secondary infections or scarring and enhancing the patient’s lifestyle quality. For example, the US government agency, Centers for Disease Control and Prevention, reported a 62% increase in PCR-confirmed varicella cases in 2022, escalating from 29% to 47% in the last five years as of 2024. Additionally, the National Foundation for Infectious Diseases, a US health organization, reported in January 2023 that there are approximately 14 million fresh HPV infection cases each year in the United States. Consequently, the surge in viral infections propels the common warts market’s growth.

Get Your Free Sample of the Global Common Warts Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

Who are the major industry leaders accelerating growth in the Common Warts market?

Major companies operating in the common warts market are Major players in the market are AbbVie Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Novan Inc., X4 Pharmaceuticals Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., RXi Pharmaceuticals Corporation, Scholl’s Wellness Company, Nielsen BioSciences Inc., Cassiopea S.p.A., Orgenesis Inc., KinoPharma Inc., Naturasil, Veradermics Inc., KinoPharma Co. Ltd.

Which Current Trends Are Having the Most Impact on the Common Warts Market?

Big players in the common warts market are concentrating their efforts on developing innovative treatments, such as dermatological therapies, in order to meet the increasing demand for effective and accessible solutions. Their end goal is to enhance patient wellbeing and broaden their reach in the dermatology industry. Dermatological therapies, in this context, imply treatments for various skin conditions like infections, inflammations, and disorders. For example, in May 2024, Verrica Pharmaceuticals, an American pharmaceutical firm, joined hands with Torii Pharmaceutical Co. Ltd., a Japanese pharmaceutical company, in a licensing agreement. The purpose of this association is to finance a worldwide Phase 3 clinical trial for YCANTH, intended for treating common warts. This partnership facilitates the later development stages of YCANTH and extends its anticipated global reach. Torii Pharmaceuticals will provide monetary support to propel the study forward. This alliance bolsters the dermatology portfolios of both firms and boosts their international presence in the market.

Get Instant Access to the Global Common Warts Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Common Warts Market?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

Which Regions Are Key Players in the Growth of the Common Warts Market?

North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Elements Shape the Definition of the Common Warts Market?

Common warts are non-cancerous skin growths caused by the human papillomavirus (HPV). They typically appear on the hands, fingers, and other areas, serving as a defense mechanism for the body in response to the viral infection.

Browse Through More Similar Reports By The Business Research Company:

Anticonvulsants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anticonvulsants-global-market-report

Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

Anti-Inflammatory Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: